30206824 10
In this review, we aim to summarize the literature regarding the
The aim of the following study is to assess the efficacy of maintaining hair growth with
However, the patient numbers of these studies
This randomized, double-blind, double dummy, parallel-group, 24-week study was conducted in adult male outpatients with AGA at 45 sites in Europe
19, 20 Goren et al reported that after 16 weeks of
The patients were treated with topical finasteride 0
Finasteride is an FDA-approved pharmacologic agent for treating benign prostate hyperplasia and androgenic alopecia (male pattern hair loss) in men
As such, hair width may not be of utility as an endpoint to monitor treatment
Objectives: To compare the efficacy of topical 5% minoxidil and 0
It’s available in various forms, including solutions, gels, and foams
Objective: To compare the efficacy and safety of topical solution of 0
125mg/ml considering a 100ml bottle
Only topical minoxidil and oral finasteride are now approved by the Food and Drug Administration and the European Medicines Agency for the treatment of androgenetic alopecia
The efficacy of topical finasteride of varying concentrations and formulations has been evaluated
International guidelines recommend topical minoxidil (5%) and oral finasteride (a type II 5-α-reductase inhibitor) for treatment of male AGA 4
05% hydroalcoholic solution) in male androgenetic alopecia patients
25% finasteride and 3% minoxidil saw more significant improvements in hair diameter (Suchonwanit et al
doi: 10
Moderate-quality evidence suggests that daily use of oral finasteride increases hair count and improves patient and A topical finasteride formulation has been developed to minimize systemic exposure by acting specifically on hair follicles